Stay updated on Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now displays the updated site revision, v3.5.3, replacing the previous v3.5.2; this indicates a software deployment rather than a change to trial information.
    Difference
    0.1%
    Check dated 2026-04-30T16:47:30.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    - Revision tag updated from v3.5.0 to v3.5.2. This appears to be a minor maintenance update and does not modify study data or visible content.
    Difference
    0.1%
    Check dated 2026-04-16T10:34:04.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T16:49:12.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no visible changes to study details or navigation.
    Difference
    0.1%
    Check dated 2026-03-11T15:21:27.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed notices for Revision: v3.4.1 and a government funding status notice. These are administrative site updates and do not affect the study details on the page.
    Difference
    0.5%
    Check dated 2026-02-11T09:17:23.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    A government funding-related notice about potential delays and current operating status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T05:22:17.000Z thumbnail image

Stay in the know with updates to Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.